Company intelligence / Profile preview

Clinical Outcomes Solutions

United States

Ownership: Private
Development stage: Other

Overview

Clinical Outcomes Solutions (COS) provides end-to-end patient-focused research and strategic consulting in Clinical Outcome Assessments (COA) for pharmaceutical sponsors across drug development, from basic research through post-marketing. They specialize in qualitative/quantitative COA research, endpoint strategies, and psychometric analysis. The company was acquired by Validant, a global consultancy in quality, compliance, and regulatory services, on May 20, 2021, which strengthened Validant's presence in COA research within health economics and outcomes research (HEOR).

Industry: Contract Research Organization

Partnerships

Top pharmaceutical and biotechnology companies

Beyond the preview

Go deeper on Clinical Outcomes Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinical Outcomes Solutions.

Explore the full profile